Does direct-to-consumer marketing have public health value? Newsletter Article 18 February 2013 Pages: 4 - 5
Use of TCAs in primary care questionable? — a study from Finland Newsletter Article 18 February 2013 Pages: 7 - 7
Formoterol, salmeterol — similar value for money in asthma Newsletter Article 18 February 2013 Pages: 8 - 8
Sn-mesoporphyrin effective in neonatal hyperbilirubinaemia Newsletter Article 18 February 2013 Pages: 10 - 10
Gene therapy achieves regulated delivery of proteins Newsletter Article 18 February 2013 Pages: 11 - 11
Adjuvant immunotherapy effective in colorectal cancer Newsletter Article 18 February 2013 Pages: 11 - 11
Immunisation with peptide sequences controls hypercalcaemia Newsletter Article 18 February 2013 Pages: 12 - 12
Botulinum toxin puts a new twist on pain therapy Sean Henahan Newsletter Article 18 February 2013 Pages: 13 - 14
Community use of intravesicular antineoplastics for TCC Newsletter Article 18 February 2013 Pages: 14 - 14
Aspirin plus dipyridamole for secondary prevention of stroke Newsletter Article 18 February 2013 Pages: 15 - 15
Repaglinide improves glycaemic control in type 2 diabetes Newsletter Article 18 February 2013 Pages: 15 - 15
Docetaxel useful in second-line treatment of NSCLC? Newsletter Article 18 February 2013 Pages: 16 - 16
Pentoxifylline reduces variceal pressure in portal hypertension Newsletter Article 18 February 2013 Pages: 20 - 20
Six deaths with third-generation OCs in New Zealand Newsletter Article 18 February 2013 Pages: 21 - 21
HIV therapy sales expected to exceed $US5 billion by 2007 Newsletter Article 18 February 2013 Pages: 22 - 22